Black Bird Biotech, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.003937 million compared to USD 0.025739 million a year ago. Net loss was USD 0.131227 million compared to USD 0.224793 million a year ago.
For the nine months, sales was USD 0.024244 million compared to USD 0.070484 million a year ago. Net loss was USD 0.595114 million compared to USD 1.42 million a year ago.